Biopredictive
France FR-MF-000003886 Last updated 21 Oct 2026
- Devices
- 12
- Registries
- EUDAMED
- FDA recalls
- 0
Catalogue
FibroTest-ActiTest Ref FibroTest-ActiTest
FibroTest N Ref FibroTest N
NashTest2 Ref NashTest2
AshTest Ref AshTest
FibroTest Ref FibroTest
SteatoTest Ref SteatoTest
SteatoScreen Ref SteatoScreen
FibroMax Ref FibroMax
SteatoTest2 Ref SteatoTest2
NashTest Ref NashTest
NASH-FibroTest Ref NASH-FibroTest
HCV-GenoFibroTest Ref HCV-GenoFibroTest
About
BioPredictive is an independent biopharmaceutical company based in France that designs and markets diagnostic tests for liver diseases, including FibroTest and NASH-FibroTest.
What Biopredictive makes
Biopredictive manufactures a range of in vitro diagnostic (IVD) tests focused on liver disease assessment, including FibroTest, FibroTest-ActiTest, FibroTest N, FibroMax, SteatoTest, SteatoTest2, SteatoScreen, NashTest, NashTest2, NASH-FibroTest, and HCV‑GenoFibroTest. These products are designed to evaluate fibrosis, steatosis, and other hepatic conditions using blood‑based biomarkers.
All of the company's IVD devices are classified under the IVD General category and are listed in the European Database on Medical Devices (Eudamed). Biopredictive is headquartered in France.
Frequently asked questions
What type of products does Biopredictive manufacture?
Biopredictive manufactures in vitro diagnostic (IVD) tests designed to assess liver diseases, including fibrosis, steatosis, and related hepatic conditions. These are blood-based biomarker tests such as FibroTest, SteatoTest, NashTest, and NASH-FibroTest, which are used to evaluate liver health without requiring invasive procedures like biopsy.
Where is Biopredictive based?
Biopredictive is headquartered in France, as stated in the company's summary and country code (FR). The company operates as an independent biopharmaceutical entity focused on developing and marketing diagnostic solutions for liver disease from its base in France.
In which regulatory registry are Biopredictive's devices listed?
Biopredictive's devices are listed in Eudamed, the European Database on Medical Devices. This registry contains information about medical devices available in the European Union, and Biopredictive's IVD tests for liver disease assessment are included in this system as part of regulatory transparency requirements.
How are Biopredictive's devices classified under regulatory frameworks?
All of Biopredictive's in vitro diagnostic devices are classified under the IVD General category. This classification applies to their range of liver disease tests, including FibroTest, SteatoTest, NashTest, and related products, indicating they are subject to general IVD regulatory requirements without being placed in higher risk classes.
Information
- Country
- France
- Address
- 218, Boulevard St-Germain, PARIS, France
- Website
- www.biopredictive.com/fr/
- facebook.com/FibroTest
- [email protected]
- Phone
- +33 6 86 80 57 97
- PRRC contact
- Catherine Bacou
- EUDAMED SRN
- FR-MF-000003886